Instrumento Inactivo

Acciones MAP Pharmaceuticals Inc.

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

MAP Pharmaceuticals Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.	26/01/13
MAP Pharmaceuticals Inc. : Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.	24/01/13
MAP Pharmaceuticals Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.	24/01/13
MAP Pharmaceuticals Inc. : INVESTOR ALERT: Brannon Law Firm, L.L.C. is Investigating the Proposed Tender Offer/Merger of MAP Pharmaceuticals, Inc. by Allergan, Inc.	23/01/13
MAP Pharmaceuticals Inc. : Law Firm Brower Piven Announces Investigation of MAP Pharmaceuticals, Inc.	23/01/13

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+7,64 %	113 mil M
REGENERON PHARMACEUTICALS, INC.	+11,02 %	106 mil M
ARGENX SE	+0,41 %	22,27 mil M
BIONTECH SE	-12,03 %	22,22 mil M
GENMAB A/S	-5,99 %	19,43 mil M
WUXI APPTEC CO., LTD.	-37,36 %	17,87 mil M
BEIGENE, LTD.	-6,11 %	17,24 mil M
NEUROCRINE BIOSCIENCES, INC.	+7,05 %	14,29 mil M
SAREPTA THERAPEUTICS, INC.	+35,56 %	12,52 mil M